Ru, "Sputnik V Vaccine Clinical Trial for Youth Conducted in Moscow"

[Image source=Yonhap News]

[Asia Economy Reporter Hyunwoo Lee] Russian authorities announced that they will begin clinical trials of the domestically produced Sputnik V vaccine on teenagers in the capital city of Moscow.

According to the Russian state news agency TASS on the 21st (local time), Anastasia Rakova, Deputy Mayor of Moscow, stated in an interview that "Starting early next month, clinical trials of the Sputnik V vaccine for teenagers aged 12 to 17 will begin in Moscow," and emphasized, "Based on the results of the clinical trials, we will be able to decide whether to include teenagers in the COVID-19 vaccination program."

The clinical trial is expected to involve 350 teenagers and will be conducted in three phases. 100 participants will be involved in phases 1 and 2, and 250 in phase 3. Currently, the preliminary selection of volunteers for phases 1 and 2 of the clinical trial is underway, Rakova explained. She added, "Teenagers will receive a lower dose of the Sputnik V vaccine than adults."

Although the number of new daily confirmed cases in Russia, which had approached 30,000 at the end of last year, dropped to around 7,000, it has recently been increasing again to nearly 20,000. According to Russian health authorities, as of the 20th, the total number of new daily confirmed cases nationwide was 17,611. Of these, nearly half, 8,305 cases, were reported in Moscow.

This content was produced with the assistance of AI translation services.